Chronic kidney disease

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 6750 indexed papers.

1 Ábel T, Benczúr B, Csajbókné ÉC. Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. European journal of clinical pharmacology 2026. link 2 Babitt JL, Berns JS, Bozkurt B, Cheung Khedairy RS, Cuevas Y, Effa EE et al.. Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD). Kidney international 2026. link 3 Furth SL, Colhoun HM, Kanbay M, Kukla A, Lim LL, MacLaughlin HL et al.. The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international 2026. link 4 Gorayeb-Polacchini FS, Silva DRD, Andrade A, Calvo ICS, Moreira JCM, Divino-Filho JC et al.. Position Statement of the Brazilian Society of Nephrology on Home Hemodialysis. Jornal brasileiro de nefrologia 2026. link 5 Samaan F, Gorayeb-Polacchini FS, Brabo AM, Fraxino PH, Ferraz FH, Cabeça ALLCR et al.. Recommendations of the Brazilian Society of Nephrology for regulating access to outpatient dialysis in the Brazilian Unified Health System. Jornal brasileiro de nefrologia 2026. link 6 Qian J, Xu Y. Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis. Clinical nephrology 2026. link 7 Malik A, Mansour HRK, Kundur SP, Hunjan A, Zaheer R. Dialysis modality and cognitive outcomes in chronic kidney disease: a systematic review and meta-analysis. Clinical and experimental nephrology 2026. link 8 Ban Y, Zhang H, Wei Q, Chen F, Wen X, Yin L. Prevalence and influencing factors of malnutrition in maintenance hemodialysis patients in China: a systematic review. Frontiers in public health 2026. link 9 Mills G. Why are cats prone to kidney disease?. The Veterinary record 2026. link 10 Wolfe WA. Is There a De Facto Silo in the Nutrition Management of Dialysis Patients? Examining the Evidence and Potential for Coordinated Interventions by Renal Dietitians and Nephrology Social Workers to Better Optimize Patients' Nutritional Status. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2026. link 11 Singh A, Ehlers NW, Chandler S, Ratanjee S, Ellis R, O'Sullivan ED. Disaster Nephrology in Action: A Tech-Augmented Response to Cyclone Alfred. Disaster medicine and public health preparedness 2026. link 12 Kim J, Kamal F, Yeung B, Lafayette R. How should we best manage the consequences of nephron loss in IgAN?. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026. link 13 Wang KC, Lin LC, Pan SY, Huang JW, Chang YC, Chiang JY et al.. Use of iodinated and gadolinium-based contrast media in patients with chronic kidney disease: Consensus statements from nephrologists, cardiologists, and radiologists at National Taiwan University Hospital. Journal of the Formosan Medical Association = Taiwan yi zhi 2026. link 14 Weightman A, Clayton P, Coghlan S. Confronting the Ethical Issues with Artificial Intelligence Use in Nephrology. Kidney360 2026. link 15 Yamada H, Katagiri D, Nunose N, Kikuchi T, Koizumi M, Suzuki M et al.. Association Between Pre-Dialysis Nephrology Care Duration and Short-Term Outcomes in Hemodialysis Patients. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2026. link 16 Cordeiro MDNA, Silva JRD, Policarpo JH, Souza DE, Barbosa JFS, Marinho PÉM. Brazilian nephrologist's knowledge of intradialytic exercise: a national survey. Jornal brasileiro de nefrologia 2026. link 17 Sousa S, Santos S, Braga B, Cunha A, Beirão I. Tele-nephrology in practice: Economic impact and primary care perspectives. Nefrologia 2026. link 18 Stabouli S, Sinha MD, Paglialonga F, Bacchetta J, Bernardor J, Drozdz D et al.. Assessment, prevention, and management of cardiovascular disease risk factors in children with chronic kidney disease, on dialysis and after transplantation: clinical practice recommendations from the European Society for Paediatric Nephrology. The Lancet. Child & adolescent health 2026. link00334-7) 19 Perez Gomez MV, Costea GC, Claus L, Cornec-Le Gall E, van Eerde AM, Lemoine S et al.. Transition of patients with hereditary nephropathies from paediatric to adult care. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026. link 20 Miyahara AK, Pepato PHM, Rocha JF, Oliveira AV, Maia JVB, Diniz V et al.. Prevalence of anemia in patients with chronic kidney disease attended at a nephrology outpatient clinic and its association with the outcome of renal replacement therapy over five years: a retrospective cohort study, Municipality of São Paulo, 2010-2018. Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil 2026. link 21 Lowney AC, Davison SN, Douglas C, Brennan F. International curriculum and core components of kidney supportive care: a guide for clinicians in palliative care. BMJ supportive & palliative care 2026. link 22 Kurita N. Clinical epidemiology for comprehensive kidney care: a framework for developing clinical research questions, from biomarkers to patient-reported outcomes. Clinical and experimental nephrology 2026. link 23 Ye WWQ, Malavade T, Bargman JM, Chan CT, Perl J. Bringing medical education "home": the university health network and St. Michael's hospital home dialysis fellowship. Current opinion in nephrology and hypertension 2026. link 24 Ijaduola EA, Quarshie A, Obialo C. Feasibility of nephrology electronic consults in an inner-city population. Clinical nephrology 2026. link 25 Sahutoglu T, Kazancioglu R, Ozkan MK, Erkasap PÇ, Ates K. Impact of renality-CASE training on knowledge, skills, and practices in peritoneal dialysis catheter placement among nephrologists. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2026. link 26 Zou G, Appel L, Crews DC, Dowdy D, Matsushita K, Riekert KA et al.. Nephrology Provider Perceptions about Recommending Influenza and COVID-19 Vaccines: A Nationwide Survey. American journal of nephrology 2026. link 27 Sugawara Y, Iwagami M, Nagasu H, Miyamoto Y, Oshima M, Kuwabara T et al.. Review no. 1: designing clinical kidney research using real-world data: research questions, data sources, and analytical skills. Clinical and experimental nephrology 2026. link 28 Caplin B, Anand S, González-Quiroz M, Madero M, Michael M, Mohan S et al.. Taking the "unknown" out of CKDu-optimizing approaches to uncover the cause(s) of epidemic-level kidney disease in low- and middle-income settings: a report from the ISN's International Consortium of CKDu Collaborators (ISN i3C). Kidney international 2026. link 29 Wu IW, Park HC, Kwek JL, Kwan L, Adiya S, Jesudason S et al.. Disease Burden and Disparities of Care for Kidney Health in the Asian Pacific Region: Summary Report From the Diversity and Equity Committee of APSN. Nephrology (Carlton, Vic.) 2026. link 30 Hirsch D, George D, Pugh D, Kwiatkowski M, Staker S, Watson J et al.. Six-Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost-Saving Analysis. Nephrology (Carlton, Vic.) 2026. link 31 Hughes A, Matus Gonzalez A, van Zwieten A, Guha C, Carter S, Coghlan D et al.. Establishing a core outcome measure for life participation in children with chronic kidney disease: a Standardized Outcomes in Nephrology-children and adolescents with chronic kidney disease (SONG-Kids) consensus workshop report. Kidney international 2026. link 32 Dickerson RR, Takei R, Cadzow M, Schurr TG, Wilcox PL, Dalbeth N et al.. Mitonuclear Discordance and Gout, Type 2 Diabetes and Chronic Kidney Disease in Aotearoa New Zealand Indigenous Māori and Pacific People. Annals of human genetics 2026. link 33 Friedman S, Akerman K, Bouwmeester C. 2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications. The Senior care pharmacist 2026. link 34 Mouheb A, Metzger M, Alencar de Pinho N, Jacquelinet C, Laville M, Massy ZA et al.. Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes. Scientific reports 2026. link 35 Latuga NM, Levy K. Medications Not Dosed Within Recommended Range for Renal Function in Patients With Chronic Kidney Disease Identified upon Hospice Admission; a Retrospective Chart Review. The American journal of hospice & palliative care 2026. link 36 Zhang H, Pan S, Li D. Analyzing the association of estimated pulse wave velocity with the risk and mortality of chronic kidney disease: a study based on the NHANES database. International urology and nephrology 2026. link 37 Ye Z, Xie E, Song C, Zhang R, Wang H, Wu C et al.. Prognostic stratification with composite insulin resistance-inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses. Cardiovascular diabetology 2026. link 38 Ferrara G, Angileri S, Palomares SM, Parozzi M, Gazineo D, Cappelletti S et al.. Nursing Management of Arteriovenous Fistula and Artificial Intelligence: A Scoping Review. Journal of renal care 2026. link 39 Mallisetty Y, Kabeil A, Bergeron CJ, Han Z, Chiu CY, Kovesdy CP et al.. Association of Monocyte-Lymphocyte Ratio with Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: A Prospective Cohort Study. Nephron 2026. link 40 Koowattanatianchai S, Kochaiyapatana P, Kanokwatanakul M, Kaladee K, Kreepala C. Pulmonary hypertension in dialysis patients: clinical insights from tricuspid regurgitation velocity (TRV)-based echocardiographic criteria. Renal failure 2026. link 41 Zhao Y, Liu C, Wei W, Cui T. Stent Placement After Percutaneous Recanalization of Superior Vena Cava Stenosis in Maintenance Hemodialysis Patients. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 42 Faucon AL, Lando S, Murata S, Grams ME, Fu EL, Welander F et al.. Trends in Major Cardiovascular Events and Bleeding Among Patients With Advanced CKD: A Nationwide Swedish Study. American journal of kidney diseases : the official journal of the National Kidney Foundation 2026. link 43 Herrington WG, Judge PK, Grams ME, Wanner C. Chronic kidney disease. Lancet (London, England) 2026. link01942-7) 44 Cases A, Puchades MJ, Casas-Todoli J, Nuñez J, Peña CJ, Gorriz JL. Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity. Renal failure 2026. link 45 Tapia-Martínez JA, Silva-Velasco DL, Beltran-Ornelas JH, Sánchez-López A, Cano-Europa E, Centurión D. Exogenous hydrogen sulfide inhibits the progression of vascular dysfunction and hypertension mediated by the renin-angiotensin system in chronic kidney disease. Biochemical pharmacology 2026. link 46 Mahajan RG, Evans M, Kizilbash S. Heart-kidney transplants linked to better outcomes compared to heart-only transplants in children with non-dialysis-dependent advanced chronic kidney disease. Pediatric nephrology (Berlin, Germany) 2026. link 47 Sumida K, Kovesdy CP. Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the "Omics" Era: Gut and Beyond. Mayo Clinic proceedings 2026. link 48 Cheema S, Khatri N, Iqbal J. Comment on: Association Between Complex Indices of Blood Cell Types and Lipid Levels With All-Cause, Cardiovascular Mortality in Hemodialysis Patients: A Multicenter Retrospective Study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2026. link 49 Zhang Z, Xing Y, Zhang F, Zhang X, Zhong Y. Cardiometabolic index (CMI) and sarcopenia as predictors of all-cause and cardiovascular mortality in chronic kidney disease: a NHANES-based cohort study. Renal failure 2026. link 50 Zubiaur J, Galeote G, Jurado-Román A, Fernández-Portales J, Romani S, Salinas P et al.. Coronary Rotational ATherectomy Elective Versus Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure: Long-Term Outcomes of CRATER Trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 51 Yin H, Gu S. Association between albumin-corrected anion gap status with all-cause and cardiovascular mortality in individuals with chronic kidney disease: A national retrospective cohort study. Medicine 2026. link 52 Deepa Y, Vijay A, Padmavathi K, Bhamini AS, Nithya Sree R, Mooventhan A. Impact of aromatherapy neck massage on resting cardiovascular parameters in patients with chronic kidney disease and secondary hypertension: A self-controlled study. Journal of bodywork and movement therapies 2026. link 53 Liu H, Wang Z, Zhou S, Lin Y, Ma G, Zhang R et al.. Association of physical activity with incident chronic kidney disease in patients with cardiovascular metabolic disease: A UK Biobank observational study. Journal of science and medicine in sport 2026. link 54 Abdel-Rahman SM, Ozbek L, Narin AE, Fidan DG, Yilmaz ZY, Orak HI et al.. Association between interleukin-6, C-reactive protein and chronic kidney disease outcomes: A systematic review and meta-analysis. European journal of internal medicine 2026. link 55 Xu Y, Wang Y, Jiang S, Li Y, Li G, Liu Y et al.. Tubule-Derived IFN-α Promotes GSDMD-Mediated Macrophage Pyroptosis to Drive Renal Inflammation and Fibrosis Through JAK2/STAT2 Activation. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 56 Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J et al.. Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension. Hypertension (Dallas, Tex. : 1979) 2026. link 57 Kramer HJ, Bakris GL. The urinary albumin-to-creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease. Journal of internal medicine 2026. link 58 Lin SC, Su IM, Lee CJ, Lai YH, Hsu BG. The correlation between serum endothelin-1 levels and aortic stiffness in patients with non-dialysis chronic kidney disease. Renal failure 2026. link 59 Wang P, Meng Y, Sun Z, Li J, Tao H. Development of an interpretable machine learning model for predicting 4-year chronic kidney disease risk in elderly hypertensive patients. International journal of medical informatics 2026. link 60 Martinez Manzano JM, Kosak Lopez E, Geller A, Wattanachayakul P, Malin J, Leguizamon R et al.. Association of borderline pulmonary artery wedge pressure with major cardiovascular events in patients with pulmonary hypertension and chronic kidney disease. Heart & lung : the journal of critical care 2026. link 61 Zheng J, Wang D, Chen D, Fang H, Chang H, Han Y et al.. Association between oxidative balance score and kidney function among Chinese adults: impact of gender, diabetes and hypertension. PeerJ 2026. link 62 Chen C, Deng R, Ju M, Ge S, Yu W, Song Q et al.. Incremental value of 24-hour central systolic blood pressure based on blood pressure phenotypes for target organ damage in non-dialysis patients with chronic kidney disease. Hypertension research : official journal of the Japanese Society of Hypertension 2026. link 63 Daschner C, Kleber ME, Berg AH, Husain-Syed F, Scherberich JE, Krämer BK et al.. Association of Serum Uromodulin and Carbamylated Albumin with All-Cause and Cardiovascular Mortality in Patients with No or Mild Chronic Kidney Disease. Clinical chemistry 2026. link 64 Eren D, Demir M, Kuzu Z, Koyuncu S, Gençer V, Arıkan T et al.. The diagnostic value of N-terminal pro-B-type natriuretic peptide for low left ventricular ejection fraction by chronic kidney disease stage. BMC nephrology 2026. link 65 Li F, Poudel B, Andrade-Silva M, Wu J, Raman A, Cruz-Morales E et al.. Cell-Specific Inducible Human . Circulation 2026. link 66 Shen Y, Placier S, Louedec L, Frère P, Vandermeersch S, Figueroa S et al.. Fibroblast-derived neuropilin 1 alleviates renal fibrosis progression. The Journal of pathology 2026. link 67 Cao MC, Jiang W, Jia RF, Pan KL, Sun J. Real-world effectiveness of rope-ladder in situ cannulation in reducing pain and complications for hemodialysis patients with autogenous arteriovenous fistula. The journal of vascular access 2026. link 68 Wang L, Cao Y, Yuan W, Hao C, Yao L, Xue C et al.. Peridialytic Erythropoietin versus Roxadustat in Hemodialysis-Dependent Chronic Kidney Disease Patients. American journal of nephrology 2026. link 69 Zhou J. Prevalence and risk factors of pulmonary hypertension in maintenance hemodialysis patients based on echocardiography. Medicine 2026. link 70 Yejin Lee L, Epstein AJ, Chatterjee S, Marcum ZA, Bengtson LGS. Clinical and economic burden of chronic kidney disease in Medicare Fee-for-Service beneficiaries with and without comorbid type 2 diabetes and heart failure: A retrospective cohort study. Journal of managed care & specialty pharmacy 2026. link 71 Zoccali C, Chinnappa S, Fernández-Fernández B, Iatridi F, Mallamaci F, Mark PB et al.. Myocardial ischaemic syndromes in chronic kidney disease: risky pathways from non-acute to acute events. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026. link 72 Wallace H, Buizen L, Badve SV, Ha JT, Ketema DB, Ronksley P et al.. Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset. Diabetes, obesity & metabolism 2026. link 73 Kato N, Goto T, Ohira T, Kinoshita H, Kurokawa K, Naganuma K et al.. Machine Learning-Based Prediction of Life-Threatening Complications During Hemodialysis in Hospitalized Patients With Poor General Conditions. Artificial organs 2026. link 74 Ferreira JP, Marques P, Anker SD, Butler J, Filippatos G, Sharma A et al.. Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials. Diabetes, obesity & metabolism 2026. link 75 Meffen A, Tyrer F, Mbah Mbahnjeck J, Khunti K, Zaccardi F, Kunutsor SK. Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England. Diabetes, obesity & metabolism 2026. link 76 Delibaş EAÖ, Köse K, Yazici C, Tokgöz B. Oxidative Stress-Related HDL Dysfunction in Hemodialysis: The Clinical Utility of MPO/PON1 and MPO/HDL-C Ratios in Cardiovascular Risk Assessment. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2026. link 77 Wong CS, Wu MY, Chen YR, Lo WC, Wu MS. Multicentre, retrospective observational study on risk factors of major cardiovascular adverse events in patients with chronic kidney disease in Taiwan. BMJ open 2026. link 78 Russo E, Cappadona F, Macciò L, Di Vincenzo J, Piaggio M, Verzola D et al.. Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension 2026. link 79 Saville KA, Zeijen VJM, Zietse R, Salih M, Hesselink DA, Daemen J. Percutaneous renal denervation in the management of kidney-related pain syndromes: a case series. Cardiovascular revascularization medicine : including molecular interventions 2026. link 80 Kharsa C, Sella G, Sammour YM, Bou Chaaya RG, Kritya M, Philip J et al.. Impact of Chronic Kidney Disease on Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions: Insights From Houston Methodist Chronic Total Occlusion Registry. Journal of the American Heart Association 2026. link 81 Yoon SY, Jeong SJ, Kim JS, Hwang HS, Jeong K. Time in Target Range of Systolic Blood Pressure and Cardiovascular Disease in Patients with Chronic Kidney Disease: A Korean Nationwide Cohort Study. American journal of nephrology 2026. link 82 Nakamura Y, Kurasawa S, Kondo T, Imaizumi T, Okazaki M, Hishida M et al.. Impact of Left Ventricular Geometry on All-Cause Mortality in Patients Undergoing Hemodialysis: A Longitudinal Observational Study. Kidney360 2026. link 83 Liabeuf S, Berdougo-Tritz J, Augey L, Laville SM, Mbarek A, Deray G et al.. QT-prolonging medications: prevalence of use and associated risks in CKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026. link 84 Zawada AM, Nitschel R, Kamerath C, Crook N, Boyington S, Erlenkoetter A. In Vitro Thrombogenicity Evaluation of Hemodialyzers. International journal of molecular sciences 2026. link 85 Shao Z, Li K, Guo H, Cheng Y, Zhang S. An oral H. Journal of controlled release : official journal of the Controlled Release Society 2026. link 86 Komaba C, Komaba H, Imagawa K, Hida M, Suga T, Kakuta T et al.. Chronic Limb-Threatening Ischemia in Patients Undergoing Hemodialysis: Epidemiology, Risk Factors, and Outcomes. Journal of atherosclerosis and thrombosis 2026. link 87 Wu M, Miao M, Li Y, Fan J, Zhu W, Niu Y et al.. Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition. Molecular therapy : the journal of the American Society of Gene Therapy 2026. link 88 Dai X, Gao Y, Fang X, Zheng H. Application of VVI layered strain technology to analyze changes in left ventricular myocardial motion in patients with uremia. PloS one 2026. link 89 Li X, Raisinghani N, Gallinat A, Santos-Gallego CG, Zhang S, La Salvia S et al.. Circulating Extracellular Vesicles in the Pathogenesis of Heart Failure in Patients With Chronic Kidney Disease. Circulation 2026. link 90 Merlo M, Zoccatelli F, Costa G, Panepinto L, Friso S, Marzano L. Aldosterone synthase inhibitors across the translational spectrum: Mechanistic foundations and emerging clinical applications. Journal of internal medicine 2026. link 91 Lu X, Liu J, Deng J, Wang C, Li Y, Wu J et al.. Differential Impact of Chronic Kidney Disease Stages on the Survival Benefit of Percutaneous Coronary Intervention: A Large Real-world Cohort Study. Angiology 2026. link 92 Weingold R, Filippatos G, Anker SD, Wanner C, Shafi T, Tangri N et al.. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. Journal of diabetes and its complications 2026. link 93 Lin NH, Hsu RY, Hsieh MY, Chan CK, Chuang SY, Liao CC et al.. Comparative associations of home and dialysis-unit blood pressure with left ventricular mass and arterial stiffness in maintenance hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension 2026. link 94 Agboola OJ, Chan JSK, Spitz JA, Chan RNC, Patel J, German C et al.. The role of inflammation in longitudinal renal function decline and incident chronic kidney disease: the multi-ethnic study of atherosclerosis. European journal of preventive cardiology 2026. link 95 Han X, Yu H, Gao Q, Wang X, Zhang L, Zhao Q et al.. Gut microbiota dysbiosis promotes chronic kidney disease-associated atrial fibrillation through activation of the NLRP3 inflammasome. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026. link 96 Sun H, Qiu H, Zhao X, Wu A, Sun N, Xiong L et al.. Endothelium-inspired coating for hemodialysis needle: Heparin-modulated sustained NO release for synergistic anti-thrombotic and anti-infective effects. Journal of controlled release : official journal of the Controlled Release Society 2026. link 97 Pedersen MZ, Skaarup KG, Landler NE, Olsen FJ, Christensen J, Johansen ND et al.. Diastolic dysfunction and the risk of end-stage kidney disease among patients with non-dialysis-dependent chronic kidney disease. The international journal of cardiovascular imaging 2026. link 98 Heerspink HJL, Grams ME, Sang Y, Ballew SH, Coresh J, Surapaneni A et al.. Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis. Annals of internal medicine 2026. link 99 Dimitrijevic ZM, Apostolovic S, Tasic DD, Cvetkovic TP, Lazarevic MV, Hozokawa K et al.. Prediction of bleeding and thromboembolic complications in patients on chronic hemodialysis with the total thrombus-formation analysis system. Platelets 2026. link 100 Wang L, Zhao L, Zhang C, Lu W, Zheng Y, Huang B. The Heavy Toll of Lifeline: An Analysis of the Multidimensional Experience and Interaction Mechanisms of Establishing Arteriovenous Fistula in Patients Receiving Haemodialysis. Journal of renal care 2026. link